🔗 Share this article

Given that America continues making historic adjustments to its immunization guidelines, a particular individual has surfaced in a surprising turn: Dr. Tracy Beth Høeg, a Danish American sports medicine doctor and epidemiologist who first made her name by questioning coronavirus vaccines throughout the global health crisis and has focused upon alleged fatalities following Covid immunization in her brief position at the Food and Drug Administration.

Planned Overhauls to Childhood Vaccine Schedule

Agency leaders had intended to announce major revisions to the pediatric vaccination calendar in December, bringing the US with the Danish vaccine program, sources say – a substantial departure that would place the US out of step with many the world with little proof for public health gain. The announcement has been postponed until the coming year.

Instead of Vinay Prasad, Dr. Høeg is set to present at the meeting. She was just designated temporary leader of the FDA’s Center for Drug Evaluation and Research (CDER), the fifth person to run the division this calendar year.

Consolidating Power at the FDA

Høeg's temporary position might represent a tighter collaboration between the drug and vaccine divisions as Høeg and Prasad consolidate power at the FDA – and it signals a increased emphasis upon dismantling already-approved immunizations at the FDA.

The new acting director has repeatedly called for discontinuing some childhood shot schedules in the US so as to align more similar to Denmark, a country with universal health coverage and a population about the size of the state of Wisconsin.

In her initial statements, she has persisted in emphasizing on vaccines – traditionally the domain of Prasad, head of the FDA’s Center for Biologics Evaluation and Research (CBER) – as opposed to drug regulation.

Questions Over Expertise

The appointee has little discernible track record in pharmaceutical research, oversight or management, which has been typical for former leaders of the Center for Biologics Evaluation and Research. She has been employed at the FDA as a senior adviser to the agency head and CBER since March.

“It seems she lacks to have any of the qualifications” for overseeing the drug-regulation department, remarked Dr. Jonathan Howard. “She’s never run a randomized controlled trial. She is not versed in running a major agency. She is not an expert in industry regulation.”

Past heads of CBER would “be deeply familiar with laws and regulations and the research of drug development”, said Janet Woodcock. “Objectively, she doesn’t have the kind of background that previous people who ran CBER have had.”

The drug center has an immense portfolio at the agency, the former commissioner stated.

“Many people just focuses on the novel medication approvals, but the generic program authorizes numerous generic drugs. There is also a biologic copycat branch, non-prescription drug unit and so forth, and all of those must be managed,” Dr. Woodcock noted. “The thing you don’t keep your eye on, that is precisely what that I always told people is going to bite you.”

Furthermore, a substantial management component to the job, which oversees over 5,000 employees. “It is a massive leadership role, if you perform it correctly,” she concluded.

Official Statement and Disputed Policies

Regarding questions about Dr. Høeg's credentials and whether this assignment represents greater collaboration among agency officials on vaccines, a press secretary said that the “concerns stem from inaccurate assumptions”.

“Her resume aligns with the responsibilities of her position,” the representative explained, pointing to the months Høeg spent guiding the agency head on “pharmaceutical safety and oversight research, including predictive safety algorithms and immunization monitoring”.

As the temporary head, Høeg takes over the agency head's controversial priority voucher program, a controversial one-day medication authorization process that allegedly troubled her former heads. “By what process are these therapies being selected for this expedited pathway? Who is making the choices?” Dr. Howard asked. “There’s a lot of confidentiality happening at the agency right now.”

In general, he remarked, “the agency looks to be trending towards less stringent regulations of all drugs, with the exception of immunizations.”

Established Track Record on Immunizations

Concerning immunizations, Dr. Høeg has a clearer, if troubling, past, some experts said. She published a analysis using unconfirmed crowd-sourced reports to determine the rate of heart inflammation after COVID-19 immunization. She counseled the state of Florida surgeon general Joseph Ladapo, who was said to have altered data to indicate COVID-19 vaccines are more dangerous than they are.

Included in her “policy goals” for the incoming government featured revising regulations for recently developed shots and halting “optional” vaccines, she remarked following the vote on a audio program. At the agency, Høeg has according to sources proposed preventing adolescent males from getting Covid vaccines.

“She is an all-around dogmatist who begins with her beliefs and works backwards to fit the science in a extremely deceptive, dishonest way,” Howard stated.

Gaining Influence and a “Campaign of Retribution”

Høeg joined other dissenters, {like|